Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
MSK News Winter 2021/2022
Translational research at MSK is speeding up discoveries to help patients like Mark Denisiuk.
To Our MSK Community
Translational research takes knowledge gained in the lab and applies it to create new therapies for patients. Craig B. Thompson writes that MSK will be able to continue to drive a revolution in our understanding of cancer and improve our ability to prevent, diagnose, and treat the disease.
Translating Science Into Cures: Bringing Fresh Hope to the Denisiuk Family
Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.
Taking Aim at Pancreatic Cancer: Reasons to Be Optimistic
Pancreatic cancer will soon become the nation’s second leading cause of cancer death, but there is reason for optimism. Vinod Balachandran is leading a clinical trial testing whether mRNA vaccines can prevent pancreatic cancer from returning after surgery.
“Beautiful Patterns in Biology”: How SKI’s Dana Pe’er Earned a Top Honor and Advocates for Women Scientists
Dana Pe’er was recently named a Howard Hughes Medical Institute Investigator — one of the highest honors in biomedical science. As part of that designation, she will receive approximately $9 million over a seven-year term, with opportunity for renewal.